Correlation Between HCW Biologics and Lumos Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Lumos Pharma, you can compare the effects of market volatilities on HCW Biologics and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Lumos Pharma.

Diversification Opportunities for HCW Biologics and Lumos Pharma

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between HCW and Lumos is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of HCW Biologics i.e., HCW Biologics and Lumos Pharma go up and down completely randomly.

Pair Corralation between HCW Biologics and Lumos Pharma

Given the investment horizon of 90 days HCW Biologics is expected to generate 68.34 times more return on investment than Lumos Pharma. However, HCW Biologics is 68.34 times more volatile than Lumos Pharma. It trades about 0.15 of its potential returns per unit of risk. Lumos Pharma is currently generating about -0.03 per unit of risk. If you would invest  50.00  in HCW Biologics on August 25, 2024 and sell it today you would earn a total of  27.00  from holding HCW Biologics or generate 54.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  Lumos Pharma

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
Lumos Pharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lumos Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Lumos Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

HCW Biologics and Lumos Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Lumos Pharma

The main advantage of trading using opposite HCW Biologics and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.
The idea behind HCW Biologics and Lumos Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format